Skip to main content
logo
Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,690.00
+260.00 (2.76%)
At close: Aug 3, 2026

KRX:271980 Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
20,45523,384-29,9685,005-13,091-12,473
Depreciation & Amortization
12,45812,31711,2979,7678,8869,133
Loss (Gain) From Sale of Assets
-8.88-12.08-7.97-0.53-9.99-30
Asset Writedown & Restructuring Costs
--478.3---607.15
Loss (Gain) From Sale of Investments
-1,091-1,091-359.57201.1-2,065-189.64
Loss (Gain) on Equity Investments
-16,957-15,493-586.8-815.1142.25-1,801
Stock-Based Compensation
599.05696.531,026578.03472.48163.17
Provision & Write-off of Bad Debts
628.36682.28-1,041-2,096-370.581,626
Other Operating Activities
7,87510,32836,1473,0696,0448,663
Change in Accounts Receivable
25,14922,145-8,235-10,856-7,98410,157
Change in Inventory
-5,628359.54369.35-10,5753,5626,334
Change in Accounts Payable
-42,584-45,595-10,390-7,620-1,6649,625
Change in Other Net Operating Assets
-3,007-13,4104,4838,362-9,069-11,498
Operating Cash Flow
-2,112-5,6903,213-4,981-15,14719,100
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-9,267-8,032-4,278-6,097-11,085-5,344
Sale of Property, Plant & Equipment
912.28.3587.6410-
Sale (Purchase) of Intangibles
-1,054-1,045-2,335-3,436-5,87391.43
Investment in Securities
-9,362-6,272-1,313-2,5241,898-845.47
Other Investing Activities
9,863-620.4351.01126.4660.95
Investing Cash Flow
-9,810-15,337-7,297-11,919-12,924-8,037

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-27,4876,22824,19616,410-
Total Debt Issued
27,29927,4876,22824,19616,410-
Short-Term Debt Repaid
------6,253
Long-Term Debt Repaid
--10,157-2,199-4,702-7,448-8,343
Total Debt Repaid
-11,184-10,157-2,199-4,702-7,448-14,596
Net Debt Issued (Repaid)
16,11517,3314,02919,4948,962-14,596
Repurchase of Common Stock
-----396.98-810.02
Dividends Paid
---728.38-728.38-947.74-1,022
Other Financing Activities
-489.25-280.7219,762-026,00127,498
Financing Cash Flow
18,81717,05023,06318,76633,61811,069

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-255.4-6251,506-321.57-63.8-62.04
Miscellaneous Cash Flow Adjustments
-0----0-0
Net Cash Flow
6,639-4,60120,4851,5455,48322,070

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-11,379-13,722-1,065-11,077-26,23213,756
Free Cash Flow Growth
------
Free Cash Flow Margin
-2.13%-2.42%-0.15%-1.52%-3.63%1.96%
Free Cash Flow Per Share
-779.98-941.70-73.10-760.21-1799.81941.63
Levered Free Cash Flow
-18,670-22,192-33,1992,8814,05220,240
Unlevered Free Cash Flow
-15,831-19,446-30,0396,6525,93321,469

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
4,4384,2814,1834,2551,805921.03
Cash Income Tax Paid
11,8849,1342,1031,643-877.053,540
Change in Working Capital
-26,069-36,501-13,771-20,689-15,15514,617